09.20.23
In 2020, Medicaid spent $220.8 billion on hospital care. Hospital care accounted for 33% of Medicaid spending.
09.11.23
There is a critical need to increase access to evidence-based care for justice-involved pregnant people with a substance use disorder (SUD)—and connect them to continued coverage and care upon release—according to national physician and policy experts in a May 2023 webinar sponsored by ...
05.10.23
At 11:59 p.m. on Thursday, May 11, 2023, the COVID-19 public health emergency declaration will conclude, more than three years after taking effect in January 2020.
05.04.23
On May 3, the Drug Enforcement Administration (DEA) issued a statement from Administrator Anne Milgram on COVID-19 telemedicine flexibilities for prescribing controlled substances in which the DEA noted that it has “decided to extend the current [public health emergency (PHE)] flexibilities ...
04.25.23
Since 2010, a reported 140 rural hospitals have closed their doors, including a record 19 hospitals in 2020 alone as a result of the financial pressures of COVID-19 compounded by many other long-standing challenges facing these health systems.
02.13.23
The Biden Administration has announced that May 11, 2023, will be the final day of the COVID-19 public health emergency (PHE) declaration, which has been in effect since January 2020.
01.12.23
In 2021, drug-related overdose deaths topped 107,000.
12.12.22
On December 1, the Senate Finance Committee released the fifth and final discussion draft of the Committee’s bipartisan mental health initiative.
11.01.22
The 340B Drug Pricing Program, which was enacted in 1992 by Section 340B of the federal Public Health Services Act, requires pharmaceutical manufacturers that participate in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health care providers and ...
09.28.22
On September 23, the Centers for Medicare & Medicaid Services (CMS) reopened the comment period for a November 2020 interim final rule titled “Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency.”